Answers with the protocol read, and the query attached.

Ask Vivo answers questions about your trial data, contextualized by the study's own documents. Every answer ships with human-reviewable reasoning steps and the query that produced it — and agents run under the user's own permissions.

Governed Clinical Trial AI

Not a chatbot. A source-backed reasoning layer.

Ask Vivo gives clinical development teams a governed AI interface to their own trial data, documents, protocol context, and operating workflows.

  • The protocol agent cites the study's own documents, page by page
  • Every answer accompanied by reviewable reasoning steps and the query that produced it
  • Role-aware — every answer reflects your permissions and blinding status
  • Visual outputs, summaries, and generated tables on demand
  • Answers trace back to source records with evidence links

"Ask the trial. See the evidence."

Ask Vivo
Medical Monitor
What is the rate of cardiac events in my study, and does the protocol require expedited reporting for them?
Answer
7 cardiac events across 5 subjects (rate 1.9/100 subject-months). Protocol §9.3.2 (p. 84) requires expedited reporting for Grade ≥3 cardiac events — 2 of the 7 meet the criteria; both flagged with source records attached for the safety team's confirmation.
↗ Source: Safety database · Protocol v4.0 pp. 84–85 · Reasoning steps + SQL attached
Data Management
Summarize missing data, pending verification, and open queries by site.
Answer
Sites 211 and 308 account for 62% of open items: 41 missing pages, 28 pending SDV, 19 open queries. Site 104's queries aged >21 days doubled since last month.
↗ Source: EDC completeness module · DM review state · Query log
In the Product

Real answers, from a demonstration trial.

Ask Vivo answering a protocol stopping-rule question, with the Trial Protocol Agent explanation panel citing the protocol text
The answer and its receipt: the protocol agent’s reasoning, shown beside the database agent’s answer. Demonstration trial, synthetic data.
Ask Vivo identifying five participants at highest dropout risk, with a structured results table
Plain-language question, structured answer — with Explain Answer one click away. Demonstration trial, synthetic data.
AI Agents

Specialized agents reason over your trial like clinical experts.

Each agent queries the governed data model, applies domain reasoning, and surfaces prioritized findings with the evidence attached. Agents inherit the user's permissions — one instance per role, blinding-aware by design.

ClinOps AgentHIGH

Enrollment gap & screen failures

Site 8 has 32 screen failures — top causes identified from screening logs. Recommendation: CRA review at Site 8; redistribute recruitment to two lower-failure sites with capacity.

Safety AgentCRITICAL

SAE documentation gaps

Cross-references ICH E2A reporting obligations: flags SAEs missing narratives or causality assessment while reporting windows are still open — before they become findings.

Data Mgmt AgentMEDIUM

Discrepancy concentration

Site 3 far exceeds the trial mean for discrepancies; two sites identified as best-practice models. Reusable rules proposed for the recurring patterns.

Clinical Science AgentSIGNAL

Subgroup hypothesis generation

Surfaces trends and hypotheses on endpoints and subpopulations — divergences by baseline strata, deviation-driven population gaps — each with the analysis attached for review.

Plus the plot agent: data visualizations and analyses generated on demand, with the code attached.

On-Demand Answers

The questions teams ask Vivo every day.

Enrollment
How many patients enrolled in the UK last month for my study?
Safety
What is the rate of cardiac events in my study?
Efficacy
Which endpoints have changed most from baseline?
Data Quality
Summarize missing data, pending verification, and open queries by site.
Translational
What are the safety trends in my biomarker-driven subpopulations?
Site Performance
Rank sites by protocol deviations, dosing issues, and data quality.
Medical History
Give me a detailed medical history for a set of patients.
Protocol Deviations
Are deviations documented and resolved for inspection?
Feasibility
How many patients did Site 103 recruit across all oncology studies this year?

Every answer is scoped to the asker's role and blinding status, enforced at the data layer — arm-level views require unblinded permissions.

"Vivo is our new best friend."

Medical Monitor · Phase 2 Rare Disease Trial

Ask your trial a question. See the evidence come back.

Governed, auditable, role-aware AI over your live trial data — in production with sponsors today.